Clear answers about joint soreness and care

Stiffness after sitting may ease with gentle movement

Joints often stiffen while they stay still, so the first few steps may hurt. Notice how long the stiffness lasts and whether gentle movement eases it. That doesn't prove arthritis or rule out another cause. I'd also note any swelling, warmth, or soreness that disturbs your sleep. Tell the examiner exactly what you notice.

Keep walking only while the soreness stays mild

Gentle walking may be worth keeping when the ache stays mild and settles afterward. Shorten the walk, slow down, or take a flatter route. Stop when sharp pain begins or the joint feels weak. If you're worse later or the next day, try less.

Heat, swelling, or sudden weakness needs prompt care

Arrange a visit when the ache limits daily tasks, keeps returning, disturbs sleep, or comes with swelling. Seek prompt help if fever comes while one joint feels hot and looks swollen. Major swelling, sudden trouble standing, or new weakness shouldn't wait for a review or a routine call.

The first visit starts with your soreness

The person seeing you will likely ask where it hurts, when the soreness began, which movements bring it on, how long it lasts, and what helps it ease again. The exam may check movement, strength, and swelling. An X-ray may help, but it won't answer every question. Before leaving, ask what to do next and when to return.

Evidence sources

1. The 2019 ACR/Arthritis Foundation guideline makes STRONG recommendations for exercise, weight loss in people with overweight or obesity, self-efficacy and self-management programmes, tai chi, cane use, hand orthoses for first-CMC joint OA, tibiofemoral bracing, topical NSAIDs for the knee, oral NSAIDs and intra-articular glucocorticoid injections for the knee; acupuncture, thermal modalities, radiofrequency ablation, acetaminophen, duloxetine and tramadol are only conditional.

   Kolasinski SL, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.. Arthritis Rheumatol, 2020.

2. The systematic literature review informing the 2018 EULAR hand osteoarthritis recommendations (127 references) found hand exercise and prolonged thumb-base splinting beneficial, topical and oral NSAIDs equally effective with fewer adverse events from topical, and NO clear benefit for paracetamol, intra-articular thumb-base glucocorticoid or hyaluronic acid injection, low-dose oral glucocorticoids, hydroxychloroquine or anti-TNF. No trial compared surgery with sham or non-operative treatment.

   Kroon FPB, et al. — Efficacy and safety of non-pharmacological, pharmacological and surgical treatment for hand osteoarthritis: a systematic literature review informing the 2018 update of the EULAR recommendations for the management of hand osteoarthritis.. RMD Open, 2018.

3. The 2010 ACR/EULAR classification criteria define 'definite rheumatoid arthritis' by confirmed synovitis in at least one joint, absence of a better alternative diagnosis, and a total score of 6 or more out of 10 across four domains: number and site of involved joints (0-5), serology (0-3), acute-phase response (0-1) and symptom duration (0-1). This is the formal boundary between inflammatory arthritis and degenerative joint disease.

   Aletaha D, et al. — 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.. Arthritis Rheum, 2010.

4. The 2025 EULAR update recommends methotrexate, ideally combined with short-term glucocorticoids, as initial therapy for rheumatoid arthritis, within a treat-to-target strategy across conventional synthetic, biological and targeted synthetic DMARDs - a disease-modifying drug pathway that has no counterpart in osteoarthritis and which belongs to rheumatology.

   Smolen JS, et al. — EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update.. Ann Rheum Dis, 2026.